Lemaitre Vascular (LMAT) Gains from Investment Securities (2017 - 2024)
Lemaitre Vascular (LMAT) posted quarterly Gains from Investment Securities of $64000.0 for Q4 2024, up 320.69% year-over-year from $15213.1 in Q1 2024, and up 166.67% quarter-over-quarter from $24000.0 in Q3 2024.
Lemaitre Vascular (LMAT) Gains from Investment Securities (2017 - 2024) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Gains from Investment Securities for 8 consecutive years, with $64000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Gains from Investment Securities rose 320.69% year-over-year to $64000.0; the TTM figure through Sep 2025 stood at $64000.0 (up 56.1% YoY), while the FY2024 annual figure was $134000.0, up 271.79% from the prior year.
- Gains from Investment Securities advanced to $64000.0 in Q4 2024 per LMAT's latest filing, from $24000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $100000.0 in Q3 2023 and bottomed at -$48.0 billion in Q3 2020.
- Historically, Gains from Investment Securities has averaged -$2.4 billion across 5 years, with a median of $23000.0 in 2023.
- Annual changes were most pronounced in 2020 — Gains from Investment Securities slumped 109091009.09% — and 2023, when it surged 470.37%.
- Lemaitre Vascular's Gains from Investment Securities stood at $50000.0 in 2020, then slumped by 540.0% to -$220000.0 in 2021, then surged by 54.55% to -$100000.0 in 2022, then surged by 71.0% to -$29000.0 in 2023, then soared by 320.69% to $64000.0 in 2024.
- Business Quant data shows LMAT's Gains from Investment Securities at $64000.0 in Q4 2024, $24000.0 in Q3 2024, and $23000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | -100,000.00 |
| Dec 31, 2022 | -100,000.00 |
| Sep 30, 2022 | -27,000.00 |
| Sep 30, 2022 | -27,000.00 |